内科学

Medicine & Life Sciences

1. Japan 100%
2. Therapeutics 72%
3. Registries 63%
4. Transcatheter Aortic Valve Replacement 63%
5. Cardiac Myocytes 57%
6. Rheumatoid Arthritis 57%
7. Heart Failure 56%
8. Hematopoietic Stem Cell Transplantation 53%
9. Kidney 53%
10. Percutaneous Coronary Intervention 49%
11. Ulcerative Colitis 47%
12. Lung 44%
13. Myasthenia Gravis 42%
14. Atrial Fibrillation 35%
15. Serum 34%
16. Safety 34%
17. Helicobacter pylori 34%
18. Induced Pluripotent Stem Cells 34%
19. Mortality 32%
20. Type 2 Diabetes Mellitus 32%
21. Confidence Intervals 32%
22. T-Lymphocytes 30%
23. Crohn Disease 30%
24. Heart 30%
25. Inflammation 30%
26. Mutation 29%
27. Genes 29%
28. Blood Pressure 27%
29. Transplantation 26%
30. Pulmonary Hypertension 26%
31. Antibodies 25%
32. tocilizumab 25%
33. Graft vs Host Disease 25%
34. Survival 24%
35. Neoplasms 24%
36. Transplants 24%
37. Odds Ratio 24%
38. Incidence 24%
39. Inflammatory Bowel Diseases 24%
40. Glucose 24%
41. Cell Transplantation 24%
42. Renin 24%
43. Chronic Renal Insufficiency 23%
44. Hypertension 23%
45. Myocardial Infarction 23%
46. Coronavirus 23%
47. Hyperaldosteronism 22%
48. Hemorrhage 22%
49. Macrophages 22%
50. Bone Marrow Transplantation 22%
51. Recurrence 22%
52. Myositis 22%
53. Colitis 21%
54. Cytokines 21%
55. Chronic Obstructive Pulmonary Disease 21%
56. Stem Cells 21%
57. Tomography 21%
58. Multicenter Studies 21%
59. Cardiovascular Diseases 21%
60. Phenotype 20%
61. Allogeneic Cells 20%
62. Endoscopic Mucosal Resection 20%
63. Liver 20%
64. Stomach 20%
65. Pulmonary Arterial Hypertension 19%
66. Autoantibodies 19%
67. Cohort Studies 18%
68. Obesity 18%
69. Catheter Ablation 18%
70. Bone Marrow 18%
71. Aldosterone 18%
72. Methotrexate 18%
73. Biomarkers 18%
74. Interferons 18%
75. Stroke 17%
76. Non-Small Cell Lung Carcinoma 17%
77. Angiotensin II 17%
78. Mycobacterium avium Complex 17%
79. Interstitial Lung Diseases 17%
80. Arterioles 17%
81. Population 17%
82. Quality of Life 17%
83. Interleukin-6 17%
84. Pluripotent Stem Cells 16%
85. Muscular Diseases 16%
86. Pharmaceutical Preparations 16%
87. Proteins 16%
88. Retrospective Studies 16%
89. Acute Coronary Syndrome 16%
90. Infections 15%
91. Balloon Angioplasty 15%
92. Anti-Idiotypic Antibodies 15%
93. Mineralocorticoid Receptors 15%
94. Tissue Donors 15%
95. Fibrosis 15%
96. Steroids 14%
97. Stem Cell Transplantation 14%
98. C-Reactive Protein 14%
99. Biopsy 14%
100. Lung Neoplasms 14%